£116.56

Academic Press Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Price data last checked 12 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 79 days • 79 data points (No recent data available)

Historical
Generating forecast...
£116.56 £115.93 £116.07 £116.21 £116.34 £116.48 £116.62 25 January 2026 13 February 2026 05 March 2026 24 March 2026 13 April 2026

Price Distribution

Price distribution over 79 days • 2 price levels

Days at Price
Current Price
67 days 12 days · current 0 17 34 50 67 £116 £117 Days at Price

Price Analysis

Most common price: £116 (67 days, 84.8%)

Price range: £116 - £117

Price levels: 2 different prices over 79 days

Description

Product Description Progress in Molecular Biology and Translational Science, Volume 167, provides the most topical, informative and exciting monographs available on a wide variety of research topics related to Models and Biological Targets in Drug Discovery for Attention Deficit Hyperactivity Disorder, Novel Targets for Parkinson-Depression Co-morbidity. Utility of Cannabidiol (CBD) in Neuropsychiatric Disorders: A Short Review of the Recent Pre-clinical and Clinical Findings, The Many Sides of Microglia in Alcohol Use Disorders, Stress, Anxiety, Molecular Targets and More, Calcineurin Signaling in Psychiatric Disorders, Emerging Evidence for the Role of Pituitary Adenylate Cyclase- Activating Peptide (PACAP) in Neuropsychiatric Disorders, and more. Review Contains cutting-edge reviews in molecular biology About the Author Shafiqur Rahman, Ph.D. is Professor of Pharmacology in the Department of Pharmaceutical Sciences at South Dakota State University (SDSU) in Brookings, USA. He received his Ph.D. in Neuropharmacology from the Memorial University of Newfoundland, Canada. Dr. Rahman completed his post-doctoral fellowship in the Department of Psychiatry from Indiana University School of Medicine in Indianapolis in USA. Prior to joining SDSU, he worked as research scientist and faculty at the University of Kentucky in Lexington, USA and the University of Toronto, Canada. Dr. Rahman's research focus is drug discovery in neuropharmacology, i.e. the development of novel therapeutic candidates for the treatment of alcohol/nicotine addiction and neuropsychiatric disorders using animal models. His research resulted in over 200 publications/presentations, including peer-reviewed scientific articles, reviews, book chapters, meeting abstracts and seminar presentations. Dr. Rahman served on numerous scientific review panels and editorial boards of several scientific Journals. He has authored or edited multiple books or Journals in drug addiction and neuropharmacology field. Dr. Rahman is also affiliated with a number of professional organizations, including Society for Neuroscience and American Society for Pharmacology and Experimental Therapeutics.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Effects of Peri-Adolescent Licit and Illicit Drug Use on the Developing CNS Part I (Volume 160) (International Review of Neurobiology, Volume 160)
96% match

Effects of Peri-Adolescent Licit and Illicit Drug Use on the Developing CNS Part I (Volume 160) (International Review of Neurobiology, Volume 160)

Academic Press

£148.85 31 Jan 2026
Effects of Peri-Adolescent Licit and Illicit Drug Use on the Developing CNS: Part II (Volume 161) (International Review of Neurobiology, Volume 161)
95% match

Effects of Peri-Adolescent Licit and Illicit Drug Use on the Developing CNS: Part II (Volume 161) (International Review of Neurobiology, Volume 161)

Academic Press

£124.99 25 Feb 2026
Animal Models for Medications Screening to Treat Addiction: Volume 126 (International Review of Neurobiology, Volume 126)
95% match

Animal Models for Medications Screening to Treat Addiction: Volume 126 (International Review of Neurobiology, Volume 126)

Academic Press

£135.85 26 Feb 2026
Psychopharmacology of Neurologic Disease: Handbook of Clinical Neurology Series (Volume 165)
94% match

Psychopharmacology of Neurologic Disease: Handbook of Clinical Neurology Series (Volume 165)

Elsevier

£174.59 26 Feb 2026
Molecular Mechanisms of Dementia: Biomarkers, Neurochemistry, and Therapy
94% match

Molecular Mechanisms of Dementia: Biomarkers, Neurochemistry, and Therapy

Academic Press

£98.89 08 Mar 2026
Neurochemical Aspects of Alzheimer's Disease: Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies
94% match

Neurochemical Aspects of Alzheimer's Disease: Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies

Academic Press

£57.02 27 Feb 2026
Drug Discovery for the Treatment of Addiction: Medicinal Chemistry Strategies
94% match

Drug Discovery for the Treatment of Addiction: Medicinal Chemistry Strategies

Wiley

£90.79 21 Feb 2026
Cannabinoids and Neuropsychiatric Disorders: 1264 (Advances in Experimental Medicine and Biology, 1264)
93% match

Cannabinoids and Neuropsychiatric Disorders: 1264 (Advances in Experimental Medicine and Biology, 1264)

Springer

£113.25 07 Mar 2026
Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders
93% match

Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders

Academic Press

£101.89 26 Jan 2026
Neuropsychopharmacology: A Tribute to Joseph T. Coyle (Advances in Pharmacology): Volume 76
93% match

Neuropsychopharmacology: A Tribute to Joseph T. Coyle (Advances in Pharmacology): Volume 76

Academic Press

£152.67 11 Mar 2026
Ischemic and Traumatic Brain and Spinal Cord Injuries: Mechanisms and Potential Therapies
93% match

Ischemic and Traumatic Brain and Spinal Cord Injuries: Mechanisms and Potential Therapies

Academic Press

£83.95 25 Feb 2026
Drugs and the Neuroscience of Behavior: An Introduction to Psychopharmacology
93% match

Drugs and the Neuroscience of Behavior: An Introduction to Psychopharmacology

Sage Publications

£145.03 05 Feb 2026
Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Psychiatry - Theory, Applications and Treatments)
93% match

Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Psychiatry - Theory, Applications and Treatments)

£139.49 07 Jan 2026
Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
93% match

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Academic Press

£90.29 28 Mar 2026
Academic Press: Nanomedical Drug Delivery for Neurodegenerative Diseases
93% match

Academic Press: Nanomedical Drug Delivery for Neurodegenerative Diseases

Academic Press

£126.48 17 Apr 2026
Springer Animal Models of Neurological Disorders Textbook
93% match

Springer Animal Models of Neurological Disorders Textbook

Springer

£112.79 18 Apr 2026
Advances in Neuropharmacology: Drugs and Therapeutics
93% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£76.70 17 Mar 2026
Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury: The Neuroscience of Traumatic Brain Injury
93% match

Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury: The Neuroscience of Traumatic Brain Injury

Academic Press

£147.55 11 Mar 2026
Genetic Models and Molecular Pathways Underlying Autism Spectrum Disorders (Volume 241) (Progress in Brain Research, Volume 241)
93% match

Genetic Models and Molecular Pathways Underlying Autism Spectrum Disorders (Volume 241) (Progress in Brain Research, Volume 241)

Academic Press

£183.89 21 Apr 2026
Cognitive, Clinical, and Neural Aspects of Drug Addiction
93% match

Cognitive, Clinical, and Neural Aspects of Drug Addiction

Academic Press

£101.29 09 Jan 2026
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
93% match

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Academic Press

£105.16 24 Feb 2026
Molecular Psychiatry
93% match

Molecular Psychiatry

MDPI AG

£61.89 25 Feb 2026
Springer - Ketamine: From Abused Drug to Rapid-Acting Antidepressant
93% match

Springer - Ketamine: From Abused Drug to Rapid-Acting Antidepressant

Springer

£114.72 14 Apr 2026
Environmental Contaminants and Neurological Disorders (Emerging Contaminants and Associated Treatment Technologies)
93% match

Environmental Contaminants and Neurological Disorders (Emerging Contaminants and Associated Treatment Technologies)

Springer

£113.02 09 Mar 2026